A, C., F, C., K, P., A, H., K, S., A, Z., . . . F, M. B. (2026). Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study. Multiple sclerosis (Houndmills, Basingstoke, England), 32(7), 747. https://doi.org/10.1177/13524585261417130
Chicago Style (17th ed.) CitationA, Corona, et al. "Pharmacogenomics of Response to Interferon-beta and Glatiramer Acetate in Multiple Sclerosis: A Multi-centric Study." Multiple Sclerosis (Houndmills, Basingstoke, England) 32, no. 7 (2026): 747. https://doi.org/10.1177/13524585261417130.
MLA (9th ed.) CitationA, Corona, et al. "Pharmacogenomics of Response to Interferon-beta and Glatiramer Acetate in Multiple Sclerosis: A Multi-centric Study." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 32, no. 7, 2026, p. 747, https://doi.org/10.1177/13524585261417130.